A detailed history of Redmile Group, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 681,150 shares of IDYA stock, worth $17.4 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
681,150
Previous 759,516 10.32%
Holding current value
$17.4 Million
Previous $26.7 Million 19.08%
% of portfolio
1.41%
Previous 1.74%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.37 - $43.05 $2.38 Million - $3.37 Million
-78,366 Reduced 10.32%
681,150 $21.6 Million
Q2 2024

Aug 14, 2024

SELL
$34.37 - $43.46 $5.61 Million - $7.09 Million
-163,162 Reduced 17.68%
759,516 $26.7 Million
Q1 2024

May 15, 2024

SELL
$34.2 - $47.13 $450,927 - $621,409
-13,185 Reduced 1.41%
922,678 $40.5 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $23 Million - $33.5 Million
935,863 New
935,863 $33.3 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.23B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.